Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2023）
摘要
NCT03982277.
更多查看译文
关键词
TB-HIV,antiretroviral therapy,dolutegravir,efavirenz,high-dose rifampicin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要